Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Allogeneic Transplants

Allogeneic stem cell transplantation for sickle cell disease. A study of patients' decisions

Bone Marrow Transplantation volume 28, pages 545–549 (2001)Cite this article

Abstract

Allogeneic stem cell transplantation is increasingly considered as a curative though risky treatment option for adults with sickle cell disease. Little is known about attitudes of adult patients and their health care providers regarding the risks and benefits of transplantation. A survey of 100 patients and their health care providers was undertaken. Assessment of risk was by a reference gamble paradigm. Comparison was made of the characteristics of those accepting substantial risk vs those not accepting risk, as well as assessment of agreement on risks recommended by health care providers and accepted by patients. Sixty-three of 100 patients were willing to accept some short-term risk of mortality in exchange for the certainty of cure. Fifteen patients were willing to accept more than 35% mortality risk. No differences in patient or disease-related variables were identified between those accepting risk and those not accepting risk. There was no agreement between the recommendations of health care providers and the risk accepted by patients. A substantial proportion of adults with sickle cell disease are interested in curative treatment, at the expense of considerable risk. The decision to accept risk is influenced by individual patient values that cannot be easily quantified and that do not correlate with the assessment of the health care provider. Given the substantial interest in curative therapy, education about and consultation for allogeneic stem cell transplantation in sickle cell patients should be encouraged. Bone Marrow Transplantation (2001) 28, 545–549.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Platt OS, Brambilla DJ, Rosse WF et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death New Engl J Med 1994 330: 1639–1644

    Article  CAS  Google Scholar 

  2. Vermylen C, Cornu G, Ferster A et al. Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium Bone Marrow Transplant 1998 22: 1–6

    Article  CAS  Google Scholar 

  3. Walters MC, Patience M, Leisenring W et al. Bone marrow transplantation for sickle cell disease New Engl J Med 1996 335: 369–376

    Article  CAS  Google Scholar 

  4. van Besien K, Bartholomew A, Stock W et al. Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell disease Bone Marrow Transplant 2000 26: 445–449

    Article  CAS  Google Scholar 

  5. Giralt S, Estey E, Albitar M et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy Blood 1997 89: 4531–4536

    CAS  Google Scholar 

  6. Sass H . Moral aspects of risk and innovation Artific Org 1997 21: 1217–1221

    Article  CAS  Google Scholar 

  7. Prayle D, Brazier M . Supply of medicines: paternalism, autonomy and reality J Med Ethics 1998 24: 93–98

    Article  CAS  Google Scholar 

  8. Kodish E, Lantos J, Siegler M et al. Bone marrow transplantation in sickle cell disease: the trade-off between early mortality and quality of life Clin Res 1990 38: 694–700

    CAS  PubMed  Google Scholar 

  9. Kodish E, Lantos J, Stocking C et al. Bone marrow transplantation for sickle cell disease – a study of parents' decisions New Engl J Med 1991 325: 1349–1353

    Article  CAS  Google Scholar 

  10. Froberg DG, Kane RL . Methodology for measuring health-state preferences – II: Scaling methods J Clin Epidemiol 1989 42: 459–471

    Article  CAS  Google Scholar 

  11. Altman DG . Practical Statistics for Medical Research Chapman and Hall: London 1995

    Google Scholar 

  12. Charache S, Terrin ML, Moore RH et al. and the investigators of the multicenter study of hydroxyurea in sickle cell anemia. Effect of hydroxyurea on the frequency of painful crisis in sickle cell disease New Engl J Med 1995 332: 1317–1322

    Article  CAS  Google Scholar 

  13. Altman DG . Some common problems in medical research In: Practical Statistics for Medical Research Chapman and Hall: London 1995 pp 396–439

    Google Scholar 

  14. Walters MC, Patience M, Leisenring W et al. Barriers to bone marrow transplantation for sickle cell anemia Biol Blood Marrow Transplant 1996 2: 100–104

    CAS  PubMed  Google Scholar 

  15. Chandy M . Management of hematological diseases: socio-economic aspects. In: Schechter GP, Hoffman R, Schrier SL, Bajus JL (eds). American Society of Hematology Education Program Book Washington 1999 pp 73–82

  16. Platt OS, Guinan EC . Bone marrow transplantation in sickle cell anemia – the dilemma of choice New Engl J Med 1996 335: 426–427

    Article  CAS  Google Scholar 

  17. Lee A, Thomas P, Cupidore L et al. Improved survival in homozygous sickle cell disease: lessons from a cohort study Br Med J 1995 311: 1600–1602

    Article  CAS  Google Scholar 

  18. Blume KG, Amylon MD . The evaluation and counseling of candidates for hematopoietic cell transplantation In: Thomas ED, Blume KG, Forman SJ (eds) Hematopoietic Cell Transplantation Blackwell Science: Oxford 1999 371–380

    Google Scholar 

  19. Quill T, Brody H . Physician recommendations and patient autonomy: finding a balance between physician power and patient choice Ann Int Med 1996 125: 763–769

    Article  CAS  Google Scholar 

  20. Ross I . Practice guidelines, patient interests and risky procedures Bioethics 1996 10: 310–322

    Article  Google Scholar 

  21. Annas GJ . A national bill of patients' rights New Engl J Med 1998 338: 695–699

    Article  CAS  Google Scholar 

  22. Brunet-Jailly J . The ethics of clinical research in developing countries IRB: a Review of Human Subjects Research 1999 21: 8–11

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Hematology and Oncology, University of Illinois at Chicago, IL, USA

    K van Besien, M Koshy, N Talishy, L Dorn, S Devine & M Yassine

  2. Department of Medical Humanities, University of Illinois at Chicago, IL, USA

    L Anderson-Shaw

  3. Department of Pediatrics and Center for Biomedical Ethics, Rainbow Babies and Childrens Hospital and Case Western Reserve University, Cleveland, OH, USA

    E Kodish

Authors
  1. K van Besien
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M Koshy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L Anderson-Shaw
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. N Talishy
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. L Dorn
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S Devine
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M Yassine
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. E Kodish
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

van Besien, K., Koshy, M., Anderson-Shaw, L. et al. Allogeneic stem cell transplantation for sickle cell disease. A study of patients' decisions. Bone Marrow Transplant 28, 545–549 (2001). https://doi.org/10.1038/sj.bmt.1703208

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1703208

Keywords

This article is cited by

Search

Advanced search

Quick links